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The	effectiveness	of	Trump’s	revived	‘drug	war’
rhetoric	has	already	been	rejected	in	Latin	America
Under	Donald	Trump,	US	federal	drug	policy	has	undergone	a	fairly	dramatic	reversal.	The	Obama
administration’s	criticisms	of	the	‘war	on	drugs’	are	gone,	replaced	by	a	seeming	return	to
eradication	policies	in	key	drug	producer	countries.	John	Collins	(LSE	US	Centre	International
Drug	Policy	Unit)	argues	that	the	Trump	administration’s	return	to	unilateral,	aggressive,	supply-side
and	law	enforcement-based	approaches	is	likely	to	face	significant	challenges	given	the	rejection	of
the	‘war	on	drugs’	in	both	the	US	and	Latin	America.
In	global	drug	policy,	doctrinal	change	can	have	major	tangible	consequences.	How	a	state	interprets	its	policy
goals	and	seeks	to	implement	them	can	have	wide	reaching	effects.	Under	the	Obama	administration,	US
national	drug	laws	remained	more	or	less	stable.	However,	the	implementation	of	US	drug	policy	domestically
and	internationally	changed	perhaps	more	radically	than	perhaps	any	time	in	the	previous	century.	The	Obama
Department	of	Justice	deprioritised	prosecution	of	non-violent	drug	offences,	openly	criticised	the	idea	of	a	‘war
on	drugs’,	painting	it,	as	a	war	on	poor	and	marginalised	communities,	and	allowed	states	and	local	jurisdictions
to	move	ahead	with	marijuana	legalisation	in	contravention	of	the	Controlled	Substances	Act.
The	Brownfield	Doctrine	and	backsliding
Further,	the	State	Department,	perhaps	reacting	to	pressure	from	a	reformist	executive	branch,	established	a	new
international	doctrine	based	on	flexible	interpretation	of	international	drug	control	treaties	and	non-intervention	in
peripheral	aspects	of	national	drug	controls.	Under	this	new	‘Brownfield	Doctrine’,	named	after	Ambassador
William	Brownfield	who	retired	from	the	US	Foreign	Service	this	month,	the	US	overtly	eschewed	its	traditional
role	as	drug	war	advocate	in	chief	and	argued	that	the	international	community	should	be	willing	to	accept	that
some	‘countries	will	legalize	entire	categories	of	drugs’	while	others	maintain	hard-line	approaches.
With	the	inauguration	of	President	Trump	US	federal	drug	policy	has	undergone	a	fairly	radical	reversal.	The
Department	of	Justice	has	reprioritised	drug	offenses,	the	administration’s	response	to	the	opioid	epidemic	has
been	confused,	lacklustre	and	the	President	has	generally	resorted	to	platitudes	about	discredited	supply	side
fixes	and	border	enforcement.	Further	his	undermining	of	the	Affordable	Care	Act	threatens	the	greatest	tool	in
the	US	drug	policy	toolkit	–	the	expansion	of	comprehensive	evidence-based	treatment	coverage.
Not	all	fronts	have	regressed	however.	On	marijuana	Attorney	General	Jeff	Sessions,	a	staunch	drug	war	hawk,
seems	thus	far	to	have	failed	in	his	effort	to	roll	back	federal	tolerance	of	state	marijuana	legalisation.	Although
the	dynamics	are	opaque,	it	seems	likely	a	combination	of	investor	interest,	congressional	pushback	and	a	fear	of
tipping	pro-legalisation	swing	states	away	from	Republican	candidates.	Meanwhile,	it	seems	the	likely	outcome	of
a	reinvigorated	federal	war	on	marijuana	would	only	be	an	acceleration	of	the	drive	towards	the	removal	of
federal	prohibitions.
Internationally	however,	it	remained	to	be	seen	how	the	new	administration	would	make	its	presence	felt.
Observers	have	quietly	noted	a	multi-frontal	push	towards	traditional	eradication	policies	in	key	producer
countries.	This	and	an	increased	linking	of	drugs	with	insurgency	and	other	defence	imperatives	point	to	a
reinvigoration	of	the	State	Department’s	traditionally	hawkish	Bureau	of	International	Narcotics	and	Law
Enforcement	(INL).
Condemnation	of	Colombia’s	drug	control	policies	shows	a	doctrinal	shift	for	the	US
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The	recent	testimony	by	INL	head,	Ambassador	William	Brownfield,	suggested	the	opening	barrage.	He	was
soon	followed	with	a	politically	taut,	on-message	statement	by	President	Trump.	Simultaneously	the	post-drug
war	policies	of	President	Santos	remain	under	sustained	attack	within	Colombia,	particularly	from	former
President	Uribe’s	right	wing	Centro	Democratico	party.	They	have	rubbished	the	development-orientation	of	the
supply	reduction	policies	in	the	peace	accord	and	pushed	for	a	rapid	return	to	aerial	fumigation	in	line	with	recent
US	demands.	The	latter	has	been	halted	by	President	Santos	following	wide	criticism	of	their	ineffectiveness,	and
evidence	that	the	chemical	used,	glyphosate,	was	causing	cancer	in	affected	communities.
Whatever	the	institutional	drivers,	the	condemnation	of	Colombian	drug	control	efforts	by	President	Trump
represent	a	radical	doctrinal	shift	for	a	number	of	reasons.	First,	it	represents	a	return	to	unstrategic	blanket
supply	side	policies	which	were	rubbished	by	the	Obama	administration.	After	decades	of	escalating	interdiction
efforts,	drug	availability	continued	to	rise	and	prices	continued	to	fall	leading	many	to	conclude	that	the	‘war	on
drugs’	was	not	only	ineffective,	but	actively	damaging.	As	President	Santos	described	it,	it	was	akin	to	‘cycling	a
stationary	bike’.
The	Trump	administration	seems	set	to	discard	these	lessons	in	favour	of	a	return	to	aggressive	supply	side	and
law	enforcement-based	approaches.	Second,	the	rumblings	within	his	administration	have	gone	further	than	drug
control	imperatives	to	reject	the	broad	underpinnings	of	the	peace	agreement	–	namely	the	participation	of	the
FARC	in	reconstruction	and	local	control	efforts.	Third,	it	represents	an	unvarnished	return	to	traditional	US
‘narcodiplomacy’	which	many	in	the	region	view	as	a	form	of	policy	imperialism.
(image	source:	Connie	Terrell,	public	domain)
This	brand	of	unilateralism	appeared	to	have	been	banished	under	the	Obama	administration.	Indeed,	much	of
the	radical	shift	in	global	drug	discourses	over	the	past	decade	were	at	least	in	part	facilitated	by	broader	US
regional	diplomacy.	This	sought	to	roll	back	on	the	perceived	unilateralism	of	the	George	W.	Bush	administration
and	thereby	foster	a	sense	of	collective	engagement,	underpinned	by	a	new	institutionalism.	Under	this
framework	bodies	such	as	the	Organization	of	American	States	(OAS)	reinvigorated	themselves,	often	adopting
the	drug	issue	as	a	sort	of	regional	policy	unifier.
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Further,	member	states	utilised	the	US	‘openness’	to	dialogue	by,	for	the	first	time	ever,	roundly	castigating	the
failures	of	the	‘war	on	drugs’.	Then	Vice-President	Joe	Biden	was	the	first	senior	US	official	to	visit	the	region	and
describe	it	as	a	‘totally	legitimate’	debate’	in	2012.	Thereafter	events	in	the	US	accelerated	with	the	legalisation	of
marijuana	in	Washington	State	and	Colorado,	thereby	drastically	curtailing	US	drug	war	‘moral	authority’.	Soon
leaders	in	the	region	questioned	why	they	should	expend	resources	repressing	the	economic	choices	of	their
farmers,	when	citizens	in	the	US	were	seeking	to	profit	from	marijuana.	The	inauguration	of	the	‘Brownfield
Doctrine’	fundamentally	represented	an	acknowledgement	of	that	new	political	reality.
However,	recent	rebuttals	of	the	Colombian	peace	deal	and	its	constituent	drug	control	components	represent	the
beginning	of	a	new	hemispheric	drug	control	doctrinal	framework	as	well	as	a	repudiation	of	much	of	the	peace
process	which	had	thus	far	received	relatively	warm	US	support.	Further,	it	represents	a	return	to	drug	war
rhetoric	and	policies	which	many	thought	had	been	confined	to	the	dustbin	of	history.
US	policy	is	often	rarely	about	drugs
Ultimately	Trump’s	threat	to	decertify	Colombia	tells	us	more	about	broader	policy	directions	under	the	new
administration	than	it	does	about	coca	in	Colombia.	First,	the	Obama	era	of	reformist	drug	policy	discourses	from
the	highest	levels	of	the	US	government	is	clearly	at	an	end.	Second,	more	hawkish	drug	warriors,	marginalised
under	the	Obama	administration	and	subjected	to	policy	formulation	that	appeared	driven	by	an	anti-drug	war
Department	of	Justice,	have	remerged	and	found	a	trump	White	House	and	Department	of	Justice	more	open	to
their	retrograde	policies.	Third,	US	policy	is	often	rarely	about	drugs,	but	often	a	function	of	broader	domestic	or
foreign	policy	goals.	Seeking	a	more	muscular	foreign	policy	as	well	as	fuelling	domestic	fears	and	then
simultaneously	generating	perceptions	that	he	is	fighting	drug	gangs,	Trump	is	willing	to	overlook	policy	lessons
of	the	past.	All	of	these	points	are	well	highlighted	by	the	Trump	administration’s	attitude	towards	perhaps	the	US’
closest	regional	ally.
With	Trump’s	statement	we	are	witnessing	a	return	to	the	rhetoric	of	the	drug	war.	However,	the	ability	of	the	US
to	mandate	this	vision	at	home	and	abroad	is	drastically	curtailed	relative	to	other	periods	of	escalation,	such	as
the	1980s	and	early	1990s.	There	is	an	absolute	rejection	of	the	‘war	on	drugs’	across	the	political	spectrum	in
the	US,	but	this	is	most	viscerally	observed	by	the	left	and	Libertarians.	Meanwhile,	governments	in	Latin	America
began	to	openly	reject	the	strategy	almost	a	decade	ago	and	seem	unlikely	to	accept	US	dictates	that	they	return
to	policies	they	view	as	having	uniformly	failed.	If	the	US	attempts	to	overplay	its	leverage	in	the	region	it	may
well	find	itself	coming	to	terms	with	the	realities	of	a	more	multipolar	global	system	as	applied	to	drug	control.
Arguing	a	right	of	interference	in	these	countries’	drug	control	efforts	given	its	role	as	a	consumer	country	may	no
longer	produce	the	desired	result.
Just	like	the	international	‘system’	of	drug	control,	the	US	will	find	itself	confronting	a	region	with	a	desire	to	find
new	alternatives	beyond	simplistic	prohibitions.	Further,	just	like	Jeff	Sessions	on	marijuana,	any	attempt	by	the
US	to	overplay	its	hand	and	prevent	this	may	simply	expedite	the	declining	influence	of	US	narcodiplomacy	in	the
region.
John	Collins	will	be	speaking	at	the	US	Centre/International	Drug	Policy	Unit	event,	“Militarisation	and	the	‘War	on
Crime’”	on	7	November	2017	at	the	LSE.	
Notes:
•	The	views	expressed	here	are	of	the	authors	and	do	not	reflect	the	position	of	the	Centre	or	of	the	LSE
•	This	article	was	first	published	at	LSE	USAPP
•	Please	read	our	Comments	Policy	before	commenting
John	Collins	–	International	Drug	Policy	Unit,	LSE	US	Centre
Dr	John	Collins	is	Executive	Director	of	the	International	Drug	Policy	Unit	and	Fellow	of	the	LSE	US
Centre.	He	is	also	coordinator	of	the	Expert	Group	on	the	Economics	of	Drug	Policy.	He	edited	the
2012	LSE	IDEAS	Special	Report	“Governing	the	Global	Drug	Wars“,	the	2014	Report	“Ending	the
Drug	Wars”	and	the	2016	Report	“After	the	Drug	Wars“.
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